Ignite Creation Date:
2024-05-05 @ 12:02 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00223548
Status:
COMPLETED
Last Update Posted:
2005-09-22
First Post:
2005-09-14
Brief Title:
MESNA for Prevention of Acute Deterioration of Renal Function Following Contrast Agent Application
Sponsor:
University of Ulm
Organization:
University of Ulm
Study Overview
Official Title:
MESNA Zur Prophylaxe Der Kontrastmittel-Induzierten Nephropathie
Status:
COMPLETED
Status Verified Date:
2002-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine wether Mesna could prevent contrast-induced nephropathy
Detailed Description:
Contrast-induced nephropathy remains a common complication of radiographic precedures Pretreatment with Mesna Sodium 2-mercaptoethane sulfonate in combination with sodium chloride is more protective than sodium chloride alone in animal models of acute renal failure
The aim of this study is therefore to determine laboratory and clinical benefit of MESNA as an adjunct to saline hydration in patients with known renal impairment receiving contrast media
The aim of this study is therefore to determine laboratory and clinical benefit of MESNA as an adjunct to saline hydration in patients with known renal impairment receiving contrast media
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None